SCHEMBL2337798

SCHEMBL2337798

C/C(=C\C1CCOC1=O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
GABRA1 P14867 1/20 0.41
TSHR P16473 1/20 0.41
GABRG2 P18507 1/20 0.41
RXRA P19793 1/20 0.41
GABRB3 P28472 1/20 0.41
RXRB P28702 1/20 0.41
GABRB2 P47870 1/20 0.41
RXRG P48443 1/20 0.41
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703230 1.00 ALDH1A1 (0.41) ALDH1A1GABRA1TSHRGABRG2RXRA
SCHEMBL15753005 0.90 ALDH1A1 (0.39) ALDH1A1GABRA1TSHRGABRG2RXRA
SCHEMBL821141 0.88 ALDH1A1 (0.38) ALDH1A1GABRA1TSHRGABRG2RXRA
SCHEMBL30578996 0.84 KDM4E (0.39) ALDH1A1TSHRTDP1MAPK1POLB
SCHEMBL11128788 0.81 MAPK1 (0.31) MAPK1POLB
SCHEMBL23480562 0.78 MEN1 (0.33) ALDH1A1MAPK1
SCHEMBL700169 0.72 CYP1A2 (0.36) ALDH1A1GABRA1TSHRGABRG2RXRA
SCHEMBL8078394 0.72
SCHEMBL28226590 0.70 MAPK1 (0.33) MAPK1POLB
SCHEMBL701236 0.70 KDM4E (0.38) ALDH1A1GABRA1TSHRGABRG2RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022258030-A1 COMPOSITION FOR 3D PRINTING, AND 3D PRINTING METHOD AND DEVICE 珠海赛纳三维科技有限公司 2022-12-15 WO claimed
CN-113388075-B Composition for 3D printing, 3D printing method and device 珠海赛纳三维科技有限公司 2023-03-24 CN disclosed
EP-2524914-B1 SULFONIC ACID DERIVATIVE COMPOUND AND NAPHTHALIC ACID DERIVATIVE COMPOUND ADEKA CORP (JP) 2019-07-03 EP disclosed
US-10248020-B2 Acid generators and photoresists comprising same ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2019-04-02 US disclosed
US-9422445-B2 Sulfonamide-containing topcoat and photoresist additive compositions and methods of use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2016-08-23 US disclosed
US-20160053129-A1 Sulfonamide-Containing Topcoat and Photoresist Additive Compositions and Methods of Use CENTRAL GLASS CO., LTD. (JP) 2016-02-25 US disclosed
US-9223217-B2 Sulfonamide-containing topcoat and photoresist additive compositions and methods of use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2015-12-29 US disclosed
US-9156785-B2 Base reactive photoacid generators and photoresists comprising same ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2015-10-13 US disclosed
US-20140186767-A1 ACID GENERATORS AND PHOTORESISTS COMPRISING SAME ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2014-07-03 US disclosed
US-8680268-B2 Sulfonic acid derivative compound and novel naphthalic acid derivative compound ADEKA CORPORATION (JP) 2014-03-25 US disclosed
EP-2524914-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND Adeka Corporation (JP) 2012-11-21 EP disclosed
US-20120289697-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND ADEKA CORPORATION (JP) 2012-11-15 US disclosed
US-20120129108-A1 BASE REACTIVE PHOTOACID GENERATORS AND PHOTORESISTS COMPRISING SAME ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2012-05-24 US disclosed
US-20110207051-A1 Sulfonamide-Containing Topcoat and Photoresist Additive Compositions and Methods of Use INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289697-A1 NOVEL SULFONIC ACID DERIVATIVE COMPOUND AND NOVEL NAPHTHALIC ACID DERIVATIVE COMPOUND TPD52L2, TST, SULT1A1 ALDH1A1 503/4885GABRA1 1933/4885TSHR 3266/4885
US-20120129108-A1 BASE REACTIVE PHOTOACID GENERATORS AND PHOTORESISTS COMPRISING SAME ALAD, APEX1, HMBS ALDH1A1 1611/4885GABRA1 651/4885TSHR 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.